Table 1.
Demographic and clinicopathological characteristics of patients (n = 22) and correlation with the disease-free interval (DFI) and overall survival (OS).
| Characteristics | No. of Patients (n = 22) |
DFS (Months) |
Long Rank Test (p Value) | OS (Months) |
Long Rank Test (p Value) |
|---|---|---|---|---|---|
| Age | |||||
| <50 >50 |
12 10 |
14 15 |
p = 0.7 | 50 103 |
p = 0.22 |
| Gender | |||||
| Male Female |
0 22 |
- 15 |
- | - 67 |
- |
| Menopausal Status | |||||
| Pre-menopausal Post-menopausal |
10 12 |
14 15 |
p = 0.58 | 50 78 |
p = 0.56 |
| Metastatic sites | |||||
| Only liver Other |
19 3 |
16 11 |
p = 0.38 | 103 50 |
p = 0.14 |
| Liver metastases | |||||
| Synchronous Metachronous |
5 17 |
N.R. 15 |
p = 0.053 | N.R. 64 |
p = 0.2 |
| N. of liver metastases | |||||
| 1 >1 |
14 8 |
15 11 |
p = 0.84 | 103 64 |
p = 0.52 |
| Systemic therapy pre-liver surgery |
|||||
| 0 ≥1 |
7 15 |
14 46 |
p = 0.1 | 50 78 |
p = 0.89 |
| Histotype | |||||
| Ductal Lobular |
20 2 |
15 2 |
p = 0.88 | 78 44 |
p = 0.36 |
| Immunophenotype | |||||
| Luminal HER2 + TNBC |
14 5 3 |
13 17 7 |
p = 0.72 | 56 73 45 |
p = 0.28 |
| Resection margin | |||||
| Negative (R0) Positive (R1) |
20 2 |
16 5 |
p = 0.005 | 78 16 |
p < 0.0001 |
DFS: disease-free survival after liver resection; OS: overall survival after liver resection. N.: number. N.R.: not reached. Italics and bold: statistical significant p-value.